Table 3.
Unadjusted smoking-related cancer incidence rates among participants in the MACS and WIHS, stratified by HIV serostatus.
HIV Seronegative | HIV Seropositive | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
No. cancers | P-yrs | IR per 100,000 | IRR [95% CI] | P-value | No. cancers | P-yrs | IR per 100,000 | IRR [95% CI] | P-value | ||
Geographic region of recruitment site | |||||||||||
West coast [ref] | 32 | 18801 | 170.2 | 91 | 24545 | 370.7 | |||||
East coast | 76 | 34552 | 220.0 | 1.3 [0.8, 2.0] | 0.26 | 140 | 36518 | 383.4 | 1.0 [0.8, 1.4] | 0.86 | |
Midwest | 10 | 10288 | 97.2 | 0.6 [0.3, 1.2] | 0.15 | 40 | 14819 | 269.9 | 0.7 [0.5, 1.1] | 0.11 | |
Calendar period | |||||||||||
Before 1996 [ref] | 22 | 24454 | 90.0 | 21 | 16983 | 123.7 | |||||
1996 - 1999 | 4 | 4046 | 98.9 | 1.1 [0.3, 3.2] | 1.00 | 27 | 9632 | 280.3 | 2.3 [1.2, 4.2] | < 0.01 | |
2000 - 2003 | 8 | 7921 | 101.0 | 1.1 [0.4, 2.6] | 0.92 | 29 | 9288 | 312.2 | 2.5 [1.4, 4.7] | < 0.01 | |
2004 - 2007 | 15 | 8180 | 183.4 | 2.0 [1.0, 4.1] | 0.06 | 47 | 11664 | 402.9 | 3.3 [1.9, 5.7] | < 0.01 | |
2008 - 2011 | 30 | 7279 | 412.1 | 4.6 [2.6, 8.3] | < 0.01 | 60 | 10275 | 583.9 | 4.7 [2.8, 8.2] | < 0.01 | |
2012 - 2015 | 23 | 6762 | 340.1 | 3.8 [2.0, 7.1] | < 0.01 | 47 | 10017 | 469.2 | 3.8 [2.2, 6.7] | < 0.01 | |
2016 - 2018 | 16 | 5001 | 319.9 | 3.6 [1.7, 7.1] | < 0.01 | 40 | 8024 | 498.5 | 4.0 [2.3, 7.2] | < 0.01 | |
Age (years) | |||||||||||
< 40 [ref] | 8 | 20781 | 38.5 | 22 | 24679 | 89.1 | |||||
40 - 49 | 18 | 19444 | 92.6 | 2.4 [1.0, 6.4] | 0.05 | 74 | 26996 | 274.1 | 3.1 [1.9, 5.2] | < 0.01 | |
50 - 59 | 44 | 14239 | 309.0 | 8.0 [3.7, 19.7] | < 0.01 | 117 | 17876 | 654.5 | 7.3 [4.6, 12.2] | < 0.01 | |
≥ 60 | 48 | 9178 | 523.0 | 13.6 [6.4, 33.3] | < 0.01 | 58 | 6332 | 916.0 | 10.3 [6.2, 17.6] | < 0.01 | |
Race/ethnicity | |||||||||||
Non-Latinx white [ref] | 67 | 43512 | 154.0 | 107 | 34094 | 313.8 | |||||
Non-Latinx black | 39 | 12910 | 302.1 | 2.0 [1.3, 3.0] | < 0.01 | 122 | 27476 | 444.0 | 1.4 [1.1, 1.9] | 0.01 | |
Other | 12 | 7207 | 166.5 | 1.1 [0.5, 2.0] | 0.90 | 42 | 14312 | 293.5 | 0.9 [0.6, 1.3] | 0.79 | |
Baseline educational attainment | |||||||||||
High school or less [ref] | 46 | 14332 | 321.0 | 146 | 30342 | 481.2 | |||||
Some college | 26 | 16147 | 161.0 | 0.5 [0.3, 0.8] | < 0.01 | 74 | 22555 | 328.1 | 0.7 [0.5, 0.9] | < 0.01 | |
College graduate | 15 | 13132 | 114.2 | 0.4 [0.2, 0.6] | < 0.01 | 22 | 10979 | 200.4 | 0.4 [0.3, 0.7] | < 0.01 | |
At least some postgraduate education | 31 | 19770 | 156.8 | 0.5 [0.3, 0.8] | < 0.01 | 29 | 11879 | 244.1 | 0.5 [0.3, 0.8] | < 0.01 | |
Annual household income | |||||||||||
< $29,999 [ref] | 35 | 19640 | 178.2 | 147 | 39335 | 373.7 | |||||
≥ $30,000 | 33 | 25318 | 130.3 | 0.7 [0.4, 1.2] | 0.24 | 42 | 20961 | 200.4 | 0.5 [0.4, 0.8] | < 0.01 | |
BMI (kg/m2) | |||||||||||
Under or normal weight (< 25) [ref] | 24 | 20864 | 115.0 | 76 | 26627 | 285.4 | |||||
Overweight (25 - 29) | 18 | 19427 | 92.7 | 0.8 [0.4, 1.5] | 0.59 | 51 | 20883 | 244.2 | 0.9 [0.6, 1.2] | 0.44 | |
Obese (≥ 30) | 17 | 13877 | 122.5 | 1.1 [0.5, 2.1] | 0.96 | 29 | 16224 | 178.7 | 0.6 [0.4, 1.0] | 0.04 | |
Smoking status | |||||||||||
Never [ref] | 16 | 20340 | 78.7 | 20 | 22155 | 90.3 | |||||
Former | 27 | 21242 | 127.1 | 1.6 [0.8, 3.2] | 0.17 | 57 | 22372 | 254.8 | 2.8 [1.7, 5.0] | < 0.01 | |
Current | 24 | 18163 | 132.1 | 1.7 [0.9, 3.4] | 0.14 | 92 | 26447 | 347.9 | 3.9 [2.4, 6.6] | < 0.01 | |
Cumulative pack-years* | |||||||||||
Never smokers [ref] | 37 | 31805 | 116.3 | 49 | 33141 | 147.9 | |||||
1 - 10 | 14 | 12592 | 111.2 | 1.0 [0.5, 1.8] | 1.00 | 67 | 20092 | 333.5 | 2.3 [1.5, 3.3] | < 0.01 | |
11 - 20 | 13 | 6682 | 194.6 | 1.7 [0.8, 3.2] | 0.16 | 52 | 10057 | 517.1 | 3.5 [2.3, 5.3] | < 0.01 | |
21 - 30 | 11 | 4644 | 236.9 | 2.0 [0.9, 4.1] | 0.07 | 36 | 5989 | 601.1 | 4.1 [2.6, 6.4] | < 0.01 | |
> 30 | 43 | 7918 | 543.1 | 4.7 [2.9, 7.5] | < 0.01 | 67 | 6603 | 1014.7 | 6.9 [4.7, 10.1] | < 0.01 | |
Years since smoking cessation† | |||||||||||
< 10 [ref] | 15 | 10131 | 148.1 | 44 | 13085 | 336.3 | |||||
10 - 19 | 7 | 5354 | 130.7 | 0.9 [0.3, 2.3] | 0.98 | 8 | 5555 | 144.0 | 0.4 [0.2, 0.9] | 0.03 | |
≥ 20 | 5 | 4171 | 119.9 | 0.8 [0.2, 2.3] | 0.90 | 19 | 3823 | 497.0 | 1.5 [0.8, 2.6] | 0.20 | |
Alcohol use | |||||||||||
Abstainer [ref] | 14 | 12615 | 111.0 | 89 | 25881 | 343.9 | |||||
> 0 to 7 drinks/week | 31 | 32542 | 95.3 | 0.9 [0.4, 1.7] | 0.74 | 54 | 33666 | 160.4 | 0.5 [0.3, 0.7] | < 0.01 | |
> 7 to 12 drinks/week | 10 | 6883 | 145.3 | 1.3 [0.5, 3.2] | 0.65 | 9 | 4644 | 193.8 | 0.6 [0.2, 1.1] | 0.12 | |
> 12 drinks/week | 10 | 7467 | 133.9 | 1.2 [0.5, 2.9] | 0.80 | 16 | 6018 | 265.9 | 0.8 [0.4, 1.3] | 0.41 | |
Smoked an illicit drug | |||||||||||
No [ref] | 108 | 44170 | 244.5 | 210 | 51565 | 407.3 | |||||
Yes | 10 | 19471 | 51.4 | 0.2 [0.1, 0.4] | < 0.01 | 61 | 24317 | 250.9 | 0.6 [0.5, 0.8] | < 0.01 | |
Injected an illicit drug | |||||||||||
No [ref] | 118 | 63013 | 187.3 | 265 | 74212 | 357.1 | |||||
Yes | 0 | 629 | 110.5 | 0.6 [−∞, 2.6] | 0.62 | 6 | 1670 | 359.3 | 1.0 [0.4, 2.2] | 1.00 | |
Took illicit drugs other than through smoking/injection | |||||||||||
No [ref] | 112 | 50417 | 222.1 | 257 | 62667 | 410.1 | |||||
Yes | 6 | 13225 | 45.4 | 0.2 [0.1, 0.5] | < 0.01 | 14 | 13215 | 105.9 | 0.3 [0.1, 0.4] | < 0.01 | |
History of injection drug use | |||||||||||
No [ref] | 100 | 59434 | 168.3 | 204 | 65911 | 309.5 | |||||
Yes | 18 | 4207 | 427.9 | 2.5 [1.4, 4.2] | < 0.01 | 67 | 9964 | 672.4 | 2.2 [1.6, 2.9] | < 0.01 | |
Any HPV | |||||||||||
No [ref] | 0 | 457 | 151.7 | 0 | 836 | 82.9 | |||||
Yes | 3 | 1240 | 215.1 | 1.4 [0.2, ∞] | 0.78 | 4 | 2388 | 153.4 | 1.9 [0.3, ∞] | 0.60 | |
Oncogenic HPV | |||||||||||
No [ref] | 1 | 1117 | 89.5 | 1 | 1864 | 53.6 | |||||
Yes | 2 | 581 | 344.2 | 3.8 [0.2, 226.8] | 0.54 | 3 | 1360 | 220.6 | 4.1 [0.3, 215.9] | 0.41 | |
Lifetime number of sexual partners | |||||||||||
< 30 [ref] | 33 | 10845 | 304.3 | 86 | 21916 | 392.4 | |||||
30 - 59 | 12 | 10328 | 116.2 | 0.4 [0.2, 0.8] | < 0.01 | 45 | 11518 | 390.7 | 1.0 [0.7, 1.4] | 1.00 | |
60 - 89 | 9 | 6458 | 139.4 | 0.5 [0.2, 1.0] | 0.04 | 26 | 5452 | 476.9 | 1.2 [0.8, 1.9] | 0.44 | |
≥ 90 | 64 | 36010 | 177.7 | 0.6 [0.4, 0.9] | 0.02 | 114 | 36996 | 308.1 | 0.8 [0.6, 1.1] | 0.11 | |
Hepatitis C virus at baseline | |||||||||||
No [ref] | 99 | 60196 | 164.5 | 188 | 64552 | 291.2 | |||||
Yes | 19 | 3060 | 620.9 | 3.8 [2.2, 6.2] | < 0.01 | 75 | 10185 | 736.4 | 2.5 [1.9, 3.3] | < 0.01 | |
CD4 cell/μl count (HIV seropositive only) | |||||||||||
< 200 [ref] | - | 37 | 9455 | 391.3 | |||||||
200 - 500 | - | 72 | 25197 | 285.7 | 0.7 [0.5, 1.1] | 0.15 | |||||
> 500 | - | 59 | 31825 | 185.4 | 0.5 [0.3, 0.7] | < 0.01 | |||||
HIV viral load detectable (HIV seropositive only) | |||||||||||
No [ref] | - | 104 | 33789 | 307.8 | |||||||
Yes | - | 55 | 24050 | 228.7 | 0.7 [0.5, 1.0] | 0.09 | |||||
HIV viral load ≥ 4,000 copies/ml (HIV seropositive only) | |||||||||||
No [ref] | - | 119 | 39778 | 299.2 | |||||||
Yes | - | 40 | 18074 | 221.3 | 0.7 [0.5, 1.1] | 0.11 | |||||
Exposure to ART (HIV seropositive only) | |||||||||||
No [ref] | - | 85 | 29323 | 289.9 | |||||||
Yes | - | 186 | 46559 | 399.5 | 1.4 [1.1, 1.8] | 0.02 | |||||
History of clinical AIDS (HIV seropositive only) | |||||||||||
No [ref] | - | 132 | 55726 | 236.9 | |||||||
Yes | - | 139 | 20156 | 689.6 | 2.9 [2.3, 3.7] | < 0.01 | |||||
Pre-ART nadir CD4 cell/μl count (HIV seropositive only) | |||||||||||
< 200 [ref] | - | 120 | 28689 | 418.3 | |||||||
≥ 200 | - | 139 | 40954 | 339.4 | 0.8 [0.6, 1.0] | 0.11 | |||||
Post-ART nadir CD4 cell/μl count (HIV seropositive only) | |||||||||||
< 200 [ref] | - | 124 | 23331 | 531.5 | |||||||
≥ 200 | - | 82 | 37673 | 217.7 | 0.4 [0.3, 0.5] | < 0.01 | |||||
Peak HIV viral load (copies/ml, HIV seropositive only) | |||||||||||
≤ 10,000 [ref] | - | 55 | 14776 | 372.2 | |||||||
> 10,000 | - | 207 | 59889 | 345.6 | 0.9 [0.7, 1.3] | 0.67 | |||||
Total | 118 | 63642 | 185.4 | 271 | 75882 | 357.1 |
Bold indicates statistically significant.
MACS = Multicenter AIDS Cohort Study; WIHS = Women’s Interagency HIV Study; P-years = person-years; IR = incidence rate; IRR = incidence rate ratio; CI = confidence interval
: Lagged by 10 years.
: Study population limited to former smoking participants.